Varicose Vein Treatment Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 6.00 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Varicose Vein Treatment Market Analysis
The varicose veins treatment market is expected to register a CAGR of 6.0% over the forecast period, 2022-2027.
The outbreak of COVID-19 is expected to impact the market significantly, as the focus of healthcare professionals has been shifted toward the treatment of COVID-19-infected patients. Thus, the treatment of non-emergency medical conditions was given lesser priority. According to the study titled "Changing Venous Practice in the COVID-19 Era: 'Never Let a Good Crisis Go to Waste' published in the Annals of Vascular Surgery in May 2021, The national health services hospital and private hospitals stopped treating people with varicose veins and their complications during the COVID-19 Lockdown. Due to a lack of anesthetic sessions, the number of varicose vein surgeries has decreased significantly, with anesthetists being preoccupied with emergency cases, both COVID and non-COVID. Also, the geriatric population and people with co-morbid conditions are generally prone to develop venous diseases, such as varicose veins. This population is also at higher risk of being infected by the SARS-CoV-2 virus. Hence, most of the interventions related to the treatment of varicose veins are reserved and deferred during the pandemic, which is expected to significantly impact the growth of the studied market.
The market for the treatment of varicose veins is majorly driven by factors such as the growing preference of the general population for minimally-invasive surgeries, the rising geriatric population, and the technological advancements in the devices used for this treatment.
Furthermore, rising prevalence of the vericose vein anticipated to drive the growth of the market. According to a research article titled "Varicose veins and its risk factors among nurses at Dhulikhel hospital: a cross sectional study" published in BMC Nursing in February 2020, varicose veins are considered one of the most common chronic venous disorders, affecting 20-60% of all adults globally. Additionally, according to the study titled "Prevalence and awareness of varicose veins among teachers in Abha, Saudi Arabia" published in the Journal of Family Medicine and Primary Care May 2020 nearly 42% of the teachers who participated in a research study were diagnosed with varicose veins in Abha, Saudi Arabia. Obesity, particularly among women, prolonged standing hours at work, and smoking, are some of the significant risk factors associated with the development of varicose veins. Additionally, varicose veins are observed to be diagnosed during pregnancies due to the enlargement of the gravid uterus, which results in hypertension and distension in the lower-extremity veins and an increase in hormone secretion, leading to the weakening of the venous walls.
Vericose vein is most prevalent in the geriatric population, moreover rising in geriatric population anticipated to boost the market. According to the World Health Organization Facts of 2021, the proportion of the global population aged 60 and up will nearly double from 12% to 22% between 2015 and 2050. By 2050, 80% of the world's elderly will live in low- and middle-income countries. The population is aging at a much faster rate than in the past.
Additionaly, growing product launches by the key market players anticipated to boost the market growth. For Instance in October 2020, THERACLION an innovative company specialized in echotherapy treatment (using High Intensity Focused Ultrasound or HIFU), has obtained CE Mark for the second generation of SONOVEIN, it's HIFU treatment solution for varicose veins.
With technological advancements and the growing focus on improvising the healthcare system, the market is expected to witness steady growth over the forecast period. However, the high costs and risks associated with the procedures involved in vein surgeries are expected to hinder the market.
Varicose Vein Treatment Market Trends
This section covers the major market trends shaping the Varicose Veins Treatment Market according to our research experts:
Laser Ablation Devices Expected to Witness Considerable Growth Over the Forecast Period
Laser ablation treatment does not involve lengthy hospital stays or discomfort during the recovery process, which provides significant benefits to the patients who are treated for varicose veins. With the help of novel technologies and advancements in research activities by the key players in the studied market, there has been increased adoption of lasers in the treatment of varicose veins.
Laser ablation technology enables doctors to close smaller varicose veins and spider veins. This treatment involves emitting strong bursts of light onto the vein, making the affected veins disappear or fade. The use of laser treatment is increasing in developed nations due to the increasing healthcare expenditure and the growing inclination toward non-invasive procedures. According to a research study titled " Compression following treatment of superficial venous incompetence: systematic review" published in the British Journal of Surgery in May 2022, laser ablation therapy was cost-effective and the preferred initial treatment for symptomatic varicose veins having a diameter of at least 3 mm, with evidence of saphenous vein reflux. Also, there is intense competition among the local manufacturers of varicose vein lasers. With the upcoming advancements in lasers and the ease of treatment provided by the same, it is expected that the segment will grow in the future.
Moreover, increasing product launch by the key market players anticipated to boost the segment growth over the forecast period. For Instance, in April 2022, Ra Medical Systems, Inc., a medical device company focusing on developing its excimer laser system to treat vascular diseases, reported the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser ablation with expanded distal optical windows.
Thus, owing to the aforementioned factors, the laser ablation devices market is expected to register healthy growth over the forecast period.
North America Expected to Dominate the Market Over the Forecast Period
North America holds the largest share of the market studied, and this trend is expected to continue over the forecast period. The major factors contributing to the growth of the varicose veins treatment market in North America include the well-developed healthcare systems in countries such as the United States and the presence of major players, which allows the higher availability of products in the market. Furthermore, due to the favorable reimbursement scenario, the people in the United States can access this treatment at an affordable cost.
According to the study titled "Risk assessment for varicose veins among city Police-A cross-sectional study" published in the Clinical Epidemiology and Global Health in December 2021, Varicose veins affect roughly 23% of adults in the United States. When spider telangiectasias and reticular veins are taken into account, the prevalence rises to 80% in men and 85% in women. The United States of America was found to be 1 in 22. Thus, the increasing burden of varicose veins in the American population is expected to drive the studied market in the North American region over the forecast period.
However, various strategies adopted by the key market players for market expansion such as product launch, merger and acquisition, collaboration and among other anticipated to boost the market in the region. For instance in April 2021, Medtronic has started an Investigation Device Exemption (IDE) study to see if the Abre venous self-expanding stent system, which is used to treat deep venous diseases, is effective and safe. Additionally, in Otober 2021, Venclose Inc., a privately-held Silicon Valley medical device company focused on innovative treatment procedures for venous reflux disease recieved FDA 510(k) clearance for Venclose Maven, a novel radiofrequency ablation (RFA) catheter for minimally invasive treatment of incompetent perforator veins (IPVs).
Thus, owing to the aforementioned factors, the vericose vein treatment market is expected to register healthy growth over the forecast period.
Varicose Vein Treatment Industry Overview
The market for varicose vein treatment is moderately competitive and comprises mostly local players. A few international companies are present, but the local companies in different geographies majorly control the overall market. With the growing medical devices market, it is predicted that more companies will penetrate the market studied and hold substantial shares over the forecast period. The major players of the market include Medtronic plc, AngioDynamics Inc., Teleflex incorporated, Lumenis, Quanta System, Biolitec AG, Syneron Medical Ltd, and Vascular Solutions Inc.
Varicose Vein Treatment Market Leaders
-
Medtronic Plc
-
AngioDynamics, Inc.
-
Lumenis
-
Teleflex Incorporated
-
Quanta System (El.en.)
*Disclaimer: Major Players sorted in no particular order
Varicose Vein Treatment Market News
In May 2022, THERACLION, a cutting-edge company working on a scalable robotic platform for non-invasive echotherapy, has launched SONOVEIN HD. This new system combines SuperSonic Imagine's (recently acquired by Hologic) cutting-edge imaging capabilities with the first and only extracorporeal therapeutic ultrasound solution.
In April 2022, I-VASC, an Italian medical device company, has closed a EUR 1.8 million Series A investment for the launch of its VELEX device. VELEX, which received CE Mark in May 2021, is a device that can be used to treat CVI and varicose veins with a procedure called Empty Vein Ablation (EVA).
Varicose Vein Treatment Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definitions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Preference for Minimally-invasive Surgeries
- 4.2.2 Technological Advancements in Devices
- 4.2.3 Growing Geriatric Population
-
4.3 Market Restraints
- 4.3.1 High Cost of the Procedure
- 4.3.2 Risk Associated with the Vein Surgeries
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
5.1 By Treatment Type
- 5.1.1 Endovenous Ablation
- 5.1.2 Injection Sclerotherapy
- 5.1.3 Surgical Ligation/Stripping
-
5.2 By Product
- 5.2.1 Ablation Devices
- 5.2.1.1 Radiofrequency Ablation Devices
- 5.2.1.2 Laser Ablation Devices
- 5.2.2 Venous Closure Products
- 5.2.3 Surgical Products
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Candela Medical (Syneron Medical Ltd)
- 6.1.2 Medtronic PLC
- 6.1.3 Boston Scientific (Lumenis Corporation)
- 6.1.4 El. En SpA Group (Quanta System)
- 6.1.5 Teleflex Incorporated
- 6.1.6 Eufoton SRL
- 6.1.7 Biolitec AG (BioMed Technology Holdings Ltd)
- 6.1.8 AngioDynamics Inc.
- 6.1.9 Alma Lasers Ltd
- 6.1.10 Sciton Inc.
- 6.1.11 Won Tech Co. Ltd
- 6.1.12 Dornier MedTech GmbH
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityVaricose Vein Treatment Industry Segmentation
Varicose veins are superficial veins present under the skin in the legs, which become enlarged and twisted. The varicose veins treatment market includes the type of treatment and the devices used for the same. The market is segmented by treatment type, product, and geography. By treatment type, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. By product, the market is segmented into ablation devices (radiofrequency ablation devices and laser ablation devices), venous closure products, and surgical products. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value of the market (in USD million) for the above segments.
| By Treatment Type | Endovenous Ablation | |
| Injection Sclerotherapy | ||
| Surgical Ligation/Stripping | ||
| By Product | Ablation Devices | Radiofrequency Ablation Devices |
| Laser Ablation Devices | ||
| By Product | Venous Closure Products | |
| Surgical Products | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Varicose Vein Treatment Market Research FAQs
What is the current Global Varicose Veins Treatment Market size?
The Global Varicose Veins Treatment Market is projected to register a CAGR of 6% during the forecast period (2024-2029)
Who are the key players in Global Varicose Veins Treatment Market?
Medtronic Plc, AngioDynamics, Inc., Lumenis, Teleflex Incorporated and Quanta System (El.en.) are the major companies operating in the Global Varicose Veins Treatment Market.
Which is the fastest growing region in Global Varicose Veins Treatment Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Varicose Veins Treatment Market?
In 2024, the North America accounts for the largest market share in Global Varicose Veins Treatment Market.
What years does this Global Varicose Veins Treatment Market cover?
The report covers the Global Varicose Veins Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Varicose Veins Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Varicose Vein Treatment Industry Report
Statistics for the 2024 Varicose Vein Treatment market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Varicose Vein Treatment analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
